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Prevention Conference VII
Obesity, a Worldwide Epidemic Related to Heart Disease and Stroke
Executive Summary
Robert H. Eckel, MD; David A. York, PhD; Stephan Rössner, MD, PhD; Van Hubbard, MD, PhD;
Ian Caterson, MD, PhD; Sachiko T. St. Jeor, PhD, RD; Laura L. Hayman, PhD, RN, FAAN;
Rebecca M. Mullis, PhD; Steven N. Blair, PED
On April 27 and 28, 2002, the American Heart Associa-tion (AHA) sponsored a scientific conference, “Obesity,
a Worldwide Epidemic Related to Heart Disease and Stroke,”
in Honolulu, Hawaii. The purpose of the conference was to
develop a plan to reduce cardiovascular diseases (CVDs)
associated with overweight and obesity. This report discusses
the activities of the 4 working groups held before the
conference, presentations at the conference, and extensive
discussions among working group members after the confer-
ence. The primary objectives of this meeting were to
● Identify the worldwide demographics and comorbidities of
obesity.
● Identify the age-dependent risk factors for the development
of obesity.
● Identify the clinical, behavioral, and community strategies
and policies for the prevention/treatment of obesity.
● Develop networks to encourage new directions in research
and collaborations for the prevention of obesity worldwide.
The major findings of each working group are presented in
this Executive Summary of the conference proceedings. The
complete conference report with references is available on-
line at http://www.circulationaha.org in the November 2,
2004, issue of Circulation.
Writing Group I: Worldwide Demographics
of Obesity
The prevalence of obesity is increasing in virtually all
populations and age groups worldwide. Although this in-
crease is most evident in the United States, it is not limited to
the more developed, affluent nations of the world. The
escalation in obesity rates reflects the upward shift in body
weights of individual populations in response to environmen-
tal changes. BMI, or weight in kilograms per square meter of
height (kg/m2), generally is accepted as a convenient mea-
surement that provides a crude indication of body fat. The
classifications of normal weight (BMI 18.5 to 24.9), over-
weight (BMI 25.0 to 29.9), and obesity (BMI 30.0) are
somewhat arbitrary but are based on international analyses of
the health impact of different BMIs.
By using approaches similar to those used for birth cohort
trends in cholesterol and blood pressure levels, Howard and
colleagues (see Writing Group II report) examined changes in
the distribution of BMI across US birth cohorts as sampled in
the National Health Examination Survey and the National
Health and Nutrition Examination Surveys I, II, and III. Data
were analyzed for 50 091 participants born between 1887 and
1975, who were examined beginning at ages 18 through 74
years between 1959 and 1994 (Figure 1). Steady and signif-
icant increases were demonstrated for each percentile of BMI,
which suggests that this rise in BMI has been occurring over
many decades and is greater at higher percentiles. Specifi-
cally, at age 50 the 10th, 25th, 50th, 75th, and 90th percentiles
of BMI (adjusted for age, race, and sex) were estimated to be
greater by 0.31, 0.51, 0.69, 1.00, and 1.37 kg/m2, respectively,
for successive 10-year increments in date of birth. These data
suggest that in the United States the dual effects of a general
upward shift in BMI distribution coupled with an accelerated
shift at the highest levels of BMI may be associated with
larger public health implications than previously predicted.
Nearly 30% of the US population is composed of diverse
ethnic groups that are broadly categorized as black or African
American, Hispanic or Latino (including primarily Mexican
Americans, Puerto Ricans, Cuban Americans, and Central
Americans), Asians (including persons born in any part of the
Asian continent or with ancestry from the Asian continent),
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Pacific Islanders, American Indians or Alaska Natives, and
Native Hawaiians. This proportion will increase to nearly
40% over the next 2 decades. The prevalence of obesity
varies considerably among these ethnic populations; there-
fore, the overall US population data provide an incomplete
picture. However, the relation of BMI to hard clinical events
or deaths is significantly different across various sex and
ethnic/racial groups.
In Europe, as in many other parts of the world, obesity
obviously is a heterogeneous condition. The definition of
“European country” has changed in the aftermath of devel-
opments in eastern and central Europe and conflicts in central
and southeast Europe. The creation of several new countries
complicates opportunities to obtain accurate data on preva-
lence and incidence in all age groups, varying socioeconomic
settings, and both sexes.
In Australia the prevalence of obesity has increased,
particularly over the past 20 years. In 1980 the prevalence of
obesity was 8.0% in women; in 2000 it had increased to
21.8%. In 1980 prevalence was 9.3% in men; in 2000 it was
19.1%. Currently in Australian adults the prevalence of
obesity is 20.5%. Among men, 67.4% have a BMI 25;
among women, the corresponding amount is 52%. The major
increase in obesity has occurred since 1989.
In China overweight is defined by a BMI of 24.0 to 27.9
and obesity by a BMI 28. In the 1990s among Chinese
adults aged 20 to 70 years, the prevalence of overweight was
22.4% and the prevalence of obesity was 3.01%. For men, the
prevalence of overweight was 20.4% and the prevalence of
obesity was 2.1%. For women, the prevalence of overweight
was 22.4% and the prevalence of obesity was 3.9%. In 1992
urban-rural differences were observed; in the urban popula-
tion mean BMI was 23.6, compared with a BMI of 21.9 in the
rural population. Because China is a country in economic
transition, dietary fat intake increased during the 1980s and
has remained stable since 1998. The overweight/obesity trend
increased rapidly in the past 17 years. In the southern part of
China (Guangzhou, Shanghai) the prevalence of overweight
once was low but has increased at a more rapid rate than in
northern China. In 1998, even in the poor rural area of
Shanxi, the prevalence of overweight reached 10%.
In Latin America epidemiological transition is well under
way (ie, the main causes of morbidity and mortality are
shifting from malnutrition and infection to chronic diseases).
This is a diverse region, both across and within nations,
ranging from poor countries, such as Haiti and Honduras, to
middle-income countries such as Argentina and Chile. Brazil
and Mexico are 2 examples of countries with marked dispar-
ities in health and economic conditions among social classes
and geographic regions. Overweight and obesity are common
in women aged 15 to 49 years. Levels of overweight and
obesity range from 30% to 50% in Bolivia, Brazil, Colom-
bia, the Dominican Republic, Guatemala, Honduras, Mexico,
Nicaragua, and Peru. In some countries the prevalence of
overweight and obesity is approaching US levels. With
greater economic development, the prevalence of obesity
rises and begins to affect rich and poor alike.
Developing populations in Africa are still battling poverty,
food insecurity, undernutrition, and infectious diseases, con-
ditions exacerbated in sub-Saharan Africa by the HIV/AIDS
epidemic. Overweight/obesity levels are rising in more de-
veloped parts of Africa, however, causing undernutrition and
overnutrition to coexist in many countries. Data from north-
ern and southern Africa suggest that obesity is characterized
by a gender difference, with the rate of obesity in women 3 to
5 times that in men. When rates of overweight are compared,
however, the difference is smaller, as indicated by the
Mauritius data presented above. In Tunisia and Morocco, the
prevalence rates of overweight in men from 1997 to 1999
were 23.3% and 28.0%, respectively, compared with 28.2%
and 33.0%, respectively, in women. The same pattern was
observed in Africans living in Cape Town, South Africa,
where the prevalence of overweight was 22.0% in men and
36.9% in women. These data suggest that overweight and
obesity emerge “earlier” in African women.
In all societies, the risk of comorbidities tends to rise with
a BMI of 20, and clear evidence exists that specific ethnic
groups are particularly vulnerable to obesity. However, con-
siderable variation exists across ethnic groups in the propor-
tion of fat and lean tissue at equivalent BMIs. Together with
other environmental-genetic interactions, this variation may
explain why the association between comorbidities and
higher BMIs differs among various ethnic groups. Education
and socioeconomic status affect the prevalence of obesity, but
the effects may be diametrically opposite in different popu-
lations around the world. Urbanization, reduced level of
physical activity, increased dietary fat, and the westernization
of diets all have been implicated as significant environmental
influences that contribute to the rapid increase in obesity
worldwide.
Overweight/obesity in children also is increasing with a
prevalence that is 2 to 3 times that of 2 decades ago. In the
United States in children and adolescents aged 6 to 19 years,
overweight prevalence (95th percentile of the Centers for
Disease Control and Prevention standard) is 13% to 14%, or
essentially 3 times the 4% to 5% prevalence rate observed in
the 1960s. Another 10% of children and adolescents in the
United States are at risk of being overweight (ie, with a BMI
between the 85th and 95th percentiles). Preschool-age chil-
dren, particularly those aged 4 to 6 years, also are affected by
the trend of increased prevalence of overweight/obesity.
Definition issues complicate the interpretation of weight
trends in children aged 2 years.
European researchers are greatly concerned that obesity is
rapidly increasing in young people. In England and Ireland,
the prevalence of obesity is 14% and 31%, respectively, in
those aged 15 to 24 years. More than 30% of 10-year-old
boys and girls in Malta, Germany, and northern Italy had a
BMI above the 85th percentile, which corresponds to an adult
BMI 25. A similar increase in overweight/obesity has been
observed among children in Australia. In Latin America,
trends of increasing obesity are present among women of
reproductive age and children aged 5 years.
Type 2 diabetes mellitus is a recent phenomenon in
children, particularly in the United States, with variances in
ethnicity, socioeconomic group, and urbanization similar to
those seen in adults. In several parts of the world, malnutri-
tion and obesity coexist in the same community, and child-
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hood undernutrition and adult obesity coexist in the same
family. As children become more overweight and obese, the
likelihood increases that overweight girls will become over-
weight women. With pregnancy, the risk of developing
glucose intolerance and gestational diabetes increases mark-
edly. Consequently, they produce heavier babies who are
themselves prone to early childhood obesity and adolescent
type 2 diabetes mellitus. A vicious intergenerational amplifi-
cation of higher birth weight, childhood obesity, and early
type 2 diabetes mellitus seems to be under way.
Future population studies should focus on the need for
accurate information for all nations, more insight into the
prevalence of childhood obesity, identification of groups that
are especially susceptible to obesity, and better understanding
of the impact of environmental factors on the increasing
prevalence of obesity.
Writing Group II: Age-Dependent Risk
Factors for Obesity and Comorbidities
A life-course approach to chronic disease classifies determi-
nants in several different ways. A “critical period” refers to a
specific period of development when an insult has lasting
effects on the structure or function of organs, tissues, and
body systems. When the effects of the insult are not long
lasting, these periods may be referred to as “sensitive” rather
than as “critical.” During critical periods the effects of an
insult may act alone or be modified by later insults. Alterna-
tively, some insults may act at any period of development,
may accumulate over time independently, or may be corre-
lated with one another through clustering. One important
insult after birth is physical inactivity. These factors are
useful for helping determine which early life events are
important in assessment of later disease. Although age-
dependent risk factors may vary worldwide, identification of
common critical or sensitive periods and plausible determi-
nants will help improve overall treatment and prevention of
overweight/obesity over the life span.
Dynamic processes that occur over the life span determine
the development of obesity and associated chronic diseases.
Perturbations, or “insults,” that determine excessive weight
gain leading to obesity may occur at any time from before
conception through embryonic, fetal, infant, child, adoles-
cent, and adult life. These insults can affect both somatic
growth and maturation of metabolic systems and may include
a range of determinants, including societal, lifestyle, biolog-
ical, and genetic factors that often act in concert with one
another.
Higher birth weight is associated with a higher body mass
index (BMI) and increased prevalence of obesity in adult life,
although the effect is relatively small. Small birth weight is
associated with increased truncal fat or a higher waist-to-hip
ratio once body mass has been taken into account. These
general patterns have been found in developed and develop-
ing countries. The importance of intrauterine life in later
obesity may be in determining vulnerability to increased body
mass in childhood or adulthood.
Factors in early childhood may lead to obesity through one
or more pathways, including metabolic programming, estab-
lishment and tracking of lifestyle behaviors, and early patho-
logical changes. Breastfeeding may protect infants against the
development of excess weight during later childhood. Most
but not all epidemiological studies demonstrate this protec-
tive effect, which could be mediated by behavioral and/or
physiological mechanisms. However, residual confounding
Figure 1. The 10th (A), 50th (B), and 90th (C) predicted or
“smoothed” percentiles of BMI are presented as a function of
age (horizontal axis) and birth cohort (individual lines, with birth
year shown to the right of each line). The solid portion of each
line indicates the ages for which data were available from the
NHANES Surveys. The dashed portion represents extrapolated
values beyond the range of observed data.
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by cultural factors associated with both the decision to
breastfeed and later obesity also is possible. Recent data also
suggest that rapid weight gain during infancy is associated
with obesity later in childhood, perhaps reflecting a combi-
nation of genetically determined catch-up growth and post-
natal environmental factors.
Adiposity rebound is most commonly measured as the age
at which BMI is at its nadir and generally occurs between
ages 4 and 8 years. Several studies have shown that earlier
age at adiposity rebound is associated with the development
of obesity. Clinical utility is limited by several factors,
however. BMI is not a direct measure of adiposity, and other
measures of fatness do not show the same associations. In
addition, early age at adiposity rebound is often a byproduct
of excess weight gain in the first years of life, itself probably
a more important etiologic factor. Moreover, BMI at age 7 or
8 years is as good a predictor of obesity as age at adiposity
rebound and is easier to measure.
Adolescence is universally recognized as a time of transi-
tion from childhood to adulthood. From the standpoint of
obesity, it is important both for the timing of obesity
development and because it is the period during which the
comorbidities related to obesity begin to appear. Obesity
during adolescence is directly associated with obesity in
adulthood. This phenomenon of tracking has important im-
plications for early efforts to prevent the development of
obesity and to treat it once it has developed. Furthermore,
obesity in adolescence is associated with the metabolic
syndrome and clustering of risk factors for the development
of CVD, including elevated blood pressure, dyslipidemia, and
increased prevalence of type 2 diabetes mellitus.
Although it is important to determine who is most at risk
for developing obesity in adulthood, the determination of risk
factors for obesity associated with comorbidities is of even
greater importance. Observations of differences in the expres-
sion of obesity-related comorbidities indicate that some
characteristics may be important in determining such risk.
These include such phenotypic characteristics as ethnicity,
distribution of body fat, fat deposition in muscles and organs,
behavioral characteristics such as physical activity, and ge-
netic factors and interactions of genetic characteristics with
the environment in which they are expressed.
The relationship of overweight/obesity to CVD risk factors
in older adults remains enigmatic. The number of overweight
and obese older adults is increasing. In addition, aging is
associated with a loss of fat-free mass (including muscle
mass) and related consequences (eg, strength, glucose dis-
posal). Despite this change in body composition, some
evidence indicates that overweight or obesity may predict a
better survival rate, particularly in African-American women.
Some overweight or obese older persons survive to an older
age, which suggests a possible protective effect of being
overweight or obese from a metabolic or CVD standpoint. It
is unclear whether overweight/obesity carries the same health
risks in older persons as it does in younger persons. Obesity
and its effect on CVD may be different in elderly persons, but
this has not been systematically examined.
The direction of research should focus on understanding
the effects of various critical periods of growth and develop-
ment on overweight/obesity and comorbidities and how these
influences may differ around the globe, when to intervene in
modifying additional weight gain or treatment of comorbidi-
ties, and perhaps when not to intervene in elderly persons.
Writing Group III: Worldwide Comorbidities
of Obesity
Obesity predisposes patients to a large number of comorbidi-
ties and increased mortality rates. Mortality associated with
excess weight increases as the degree of obesity and over-
weight increases. One study estimated that from 280 000 to
325 000 deaths annually in the United States could be
attributed to obesity. The increase in number of deaths from
obesity is not unique to the United States; it has been
documented in a number of studies from around the world.
Coronary heart disease (CHD) and stroke are foremost in
the global burden of obesity and CVD. The Global Burden of
Disease Study ranked these conditions first and second
among all categories of death in worldwide mortality for
1990 and projected that these conditions would continue to
rank first and second among causes of death up to 2020. Heart
failure due to atherosclerosis and hypertension is a closely
related condition clinically but was not analyzed separately.
Other conditions (eg, rheumatic heart disease, Chagas dis-
ease) add to the burden of heart failure in many countries.
The World Heart Federation has compiled extensive data
on the burden of CVD in major geopolitical regions of the
world (more information is available at www.world-
heart.org). By 1996 the proportion of deaths attributable to
circulatory conditions was estimated to be 29.0% worldwide,
45.6% in developed countries, and 24.5% in developing
countries, the latter increasing from 16%—or by one half—as
estimated by the World Health Organization (WHO) in 1980.
From 1990 to 2010 the corresponding increases in industrial
market economies, economies in transition, and developing
countries were projected to be 1.8%, 19.4%, and 28.2%,
respectively. Thus, the global burden of these cardiovascular
conditions is great and growing.
Variations among countries in the occurrence of these
conditions were first investigated systematically in the Seven
Countries Study, beginning in the late 1950s and 1960s. A
10-fold range in incidence of CHD was found in the Seven
Countries Study among 16 cohorts of middle-aged men in
Europe, Japan, and the United States. These differences were
explained primarily by differences in dietary fat consumption,
blood cholesterol concentration, and blood pressure among
the cohorts, but not by differences in BMI. This finding
possibly was the result of the narrow range and mainly
“normal” mean values of BMI at baseline among the cohorts.
In addition, because of the wartime dietary conditions of most
of these populations at the time of baseline examinations,
BMI may have measured relatively greater amounts of lean
mass and less fat mass than would be the case for today’s
populations in the same areas.
More recently a similarly wide range of incidence and
mortality rates from CHD was observed in the WHO
MONICA Project, which was conducted in 31 countries from
the mid-1980s through the mid-1990s. The majority of study
populations were from Europe, although Australia, China,
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New Zealand, and the United States were included. Ten-year
trends in fatal and nonfatal CHD events were compared with
trends in BMI as measured in population samples in the same
study areas. The results depended on inclusion or exclusion of
anomalous findings from 5 populations in the Common-
wealth of Independent States that experienced decreases in
BMI. Only after these populations were excluded from
analysis did change in BMI contribute importantly to the
observed trends in coronary event rates, explaining 31% and
10% for men and for women, respectively, of the variation.
On a population-wide basis, the contribution of BMI in the
overweight and obese ranges to the pandemic of CHD and
stroke is at least partly independent of the major risk factors:
elevated blood cholesterol concentration, high blood pres-
sure, physical inactivity, and cigarette smoking. However,
complex interrelationships exist between obesity and all of
these risk factors, some of which are in the causal pathway,
and others may be effect modifiers of the obesity and health
association. More important, as the prevalence of overweight
has increased in pediatric age groups, so has the frequency of
diagnosis of complications of obesity typically seen in the
adult population. Risk factors for the development of CHD
coexist in obese adolescents, and studies have demonstrated
that BMI and abdominal panniculus are related to early
atherosclerosis in children and young adults who died from
accidents, homicides, or suicides.
Type 2 diabetes mellitus is strongly associated with obesity
in all ethnic groups. Projections by the WHO show an
alarming rate of increase in the prevalence of diabetes over
the next decade (Table), due in large part to the increasing
prevalence of obesity and physical inactivity. Important
regional differences in the rate of increase in diabetes have
been recognized, with the lowest rates of increase in North
America, Europe, and Australia and the highest rate of
increase in Asia.
The risk of type 2 diabetes mellitus increases with the
degree and duration of obesity and with the central distribu-
tion of body fat. A study of 51 000 male health professionals
in the United States found a strong positive association
between overall obesity as measured by BMI and risk of
diabetes. The relative risk for diabetes in men with a BMI of
35 kg/m2 was 40 times higher than that for men with a BMI
of 23. A similarly strong curvilinear relationship between
BMI and risk of type 2 diabetes mellitus was found in
women. The lowest risk was associated with a BMI 22. At
a BMI 35 the relative risk for diabetes adjusted for age
increased to 61. Risk may be further increased by sedentary
lifestyle or decreased by exercise. Weight gain after age 18 in
women and age 20 in men also increased the risk of type 2
diabetes mellitus. Among the Pima Indians (a group with a
particularly high incidence of type 2 diabetes mellitus), for
example, body weight gradually increased 30 kg (from 60 to
90 kg) in the years preceding the diagnosis of diabetes. In
long-term follow-up studies a strong relationship also was
demonstrated between the duration of obesity and change in
plasma glucose concentrations during an oral glucose toler-
ance test.
Insulin resistance with hyperinsulinemia is characteristic of
obesity and physical inactivity and is present before the onset
of hyperglycemia. With obesity, early demonstrable changes
are alterations in insulin-mediated antilipolysis, impairment
in glucose removal, and increased glucose production, which
result in hyperinsulinemia. Hyperinsulinemia also is associ-
ated with increases in hepatic very-low-density lipoprotein
triglyceride synthesis, plasminogen activator inhibitor-1 syn-
thesis, sympathetic nervous system activity, and sodium
reabsorption. These changes contribute to dyslipidemia and
hypertension in obese subjects. The insulin resistance char-
acteristic of type 2 diabetes mellitus probably results from a
combination of obesity and genetic factors. The mechanism
by which obesity induces insulin resistance is poorly under-
stood. Many factors, including free fatty acids, tumor necrosis
factor-, pattern of fat distribution, and multiple genetic
abnormalities, may be important and may be interactive.
Nonalcoholic fatty liver disease (NAFLD) is one of the
most common abnormalities observed in obese persons and
refers to a wide spectrum of liver disease. Classically,
suspicion of NAFLD is raised by an elevation of serum
transaminases in the absence of excessive alcohol intake,
negative serology for viral hepatitis, no autoimmune disease,
and lack of other known causes of liver disease. Imaging
studies are consistent with steatosis. A liver biopsy shows
steatosis; inflammatory cell infiltration with portal predomi-
nance, often surrounding ballooned hepatocytes; and fibrosis
that will eventually progress to severe cirrhosis. Nonalcoholic
steatohepatitis, a term used in earlier reports of liver disease
associated with obesity, is only one stage in the spectrum of
NAFLD. It is not clear why simple steatosis develops only in
some persons, whereas others progress to severe cirrhosis. It
has been estimated, however, that severe fibrosis occurs in up
to 50% of persons with NAFLD, and cirrhosis develops in 7%
to 16%. Dyslipidemia and insulin resistance both are strongly
associated with the presence of NAFLD, and limited data
suggest a correlation between the severity of the metabolic
disorder and the severity of liver disease.
Obstructive sleep apnea is highly associated with obesity.
When obstructive sleep apnea is unrecognized and untreated,
substantial comorbidities (eg, pulmonary hypertension, right
heart failure, cardiac arrhythmias, sudden death) can occur. It
has been suggested that obstructive sleep apnea contributes to
a substantial proportion of excess morbidity and mortality in
obese persons.
Overall, health risks and mortality increase as the degree of
overweight increases. Many of these health risks, such as
TABLE 1. Estimates of Regional Prevalence of Diabetes in
2000 and 2010 in Millions of Cases
Region 2000 2010 Increase, %
North America 14.2 17.5 23
Europe 26.5 32.0 24
Australia 1.0 1.3 33
South America 15.6 22.5 44
Africa 9.4 14.1 50
Asia 84.5 132.3 57
World average 151 221 46
Data from Zimmet et al, 2001.
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CVD, diabetes, liver and gallbladder diseases, and some
forms of cancer, are associated with central or abdominal
obesity. Certain musculoskeletal disorders, varicose veins,
and skin ulcerations, however, are examples of health condi-
tions that do not require central or abdominal obesity.
Evidence also exists that physical activity patterns, age,
gender, race, and ethnicity all affect the development of
comorbidities in obese persons and the BMI at which they
occur. For instance, in the United States the association of
obesity with all-cause mortality is greater for white men than
it is for African-American women. In Asian populations
diabetes develops at a lower BMI. Small birth size is
associated with higher mortality from CVD and higher levels
of risk factors, including type 2 diabetes and hypertension.
These relationships suggest that part of the risk for CVD may
be “programmed” in utero. Additional insight into these
differences is strongly needed.
The research agenda should include long-term studies to
determine why overweight/obesity and relationship to CVD
and other complications differ between populations and
ethnic groups, what predisposes patients with excess abdom-
inal adipose tissue to comorbidities, and whether weight
reduction can favorably modify the incidence/prevalence of
CVD and other comorbidities.
Writing Group IV: Prevention/Treatment
The prevalence of obesity is increasing in most of the world,
but issues in both prevention and treatment differ among
countries, on the basis of a variety of factors. In countries in
which the prevalence of obesity is relatively low, true
primordial prevention may be possible. For many countries,
however, the response to the obesity epidemic must include
both primary and secondary prevention of obesity.
High-risk and population-based approaches are comple-
mentary strategies that provide a continuum of interventions.
Supportive environments will increase the availability of
healthy choices in foods and activities and promote the
adoption of these behaviors by overweight persons. Con-
sumer pressure for those goods, services, and environments
will increase, ensuring that these choices will continue to be
available.
The epidemiological triad (Figure 2) approach is a plausi-
ble way to address the problem of obesity. This approach
requires the identification of host factors (biology, behavior,
physiological adjustments), vectors (energy density of food,
portion size, labor-saving devices), and environments (phys-
ical, economic, policy, sociocultural) to develop and imple-
ment coherent strategies.
The components of the epidemiological triad are obviously
interconnected, but the strategies for intervention differ some-
what for each. Host-related strategies tend to be educational
(one-on-one and public education, behavioral interventions)
or medical (pharmaceutical, surgical). Vector-related solu-
tions often are based on technology or engineering or other-
wise modifying the carrier of the agent. Environment-related
solutions can be physical (changing the structures and avail-
ability of goods, services, and amenities), economic (influ-
encing cost of goods and services and income to pay for
them), policymaking (changing rules), or sociocultural (influ-
encing attitudes, beliefs, and perceptions). Historically, phys-
ical activity and nutrition intervention strategies have been
dominated by the education-based approach or individual/
small behaviorally based interventions; the use of environ-
mental options has been more limited.
Treatment of Obesity
The treatment of obesity typically occurs in a healthcare
setting, although not all physicians give high priority to the
identification and treatment of obesity. Several factors con-
tribute to the relative lack of obesity treatment. Many physi-
cians are discouraged by the lack of success, which is partly
due to the lack of efficacious tools. Unfortunately, obese
patients often are stigmatized in healthcare settings, and an
atmosphere of “blame the victim” exists.
At a minimum, all healthcare providers should measure
each patient’s height and weight, determine BMI and waist
girth, and refer to the National Institutes of Health guidelines
for the treatment of patients who are overweight or obese.
Such patients should be counseled about the importance of a
healthy lifestyle, including a healthy diet and regular physical
activity. Some patients may need pharmacological or surgical
intervention. It is also important to advocate policy change so
that Medicare and Medicaid classify obesity as a disease and
provide reimbursement for its treatment. In addition to
healthcare settings, obesity treatment programs should be
Figure 2. The epidemiological triad as it
applies to obesity. The determinants are
at each corner, and the circles refer to
the dominant strategies available to
address them. Swinburn B, Egger G.
Preventive strategies against weight gain
and obesity. Reproduced with permis-
sion from Obes Rev. 2002;3:289–301.
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expanded into other settings (eg, home, school, work site,
community) to reinforce treatment efforts.
Prevention of Obesity
The prevention of overweight and obesity will require exten-
sive changes in many aspects of society. Much can be done to
restructure physical, social, and overall community environ-
ments to promote healthier lifestyles and reduce the risk
associated with a positive energy balance.
● Family/home setting. Families need to be encouraged to
become aware of more healthy food choices and implement
better menu planning. The return of the family meal will be
useful in many instances. Families should look for oppor-
tunities for physical recreational activities and focus on
integrating more physical activity into their daily routines.
● School setting. Schools should make more intensive efforts
to provide meals that offer a variety of foods with high
nutritional value and controlled-energy density. School
lunch programs also should provide opportunities for
enhancing nutrition education. School health and physical
education programs should be structured to promote
healthy eating and regular physical activity.
● Work site setting. Work sites can provide a variety of
programs that promote healthy eating and regular physical
activity. These programs can range from formal classes and
interventions to efforts to improve the physical environ-
ment to increase the frequency of routine physical activity.
● Community setting. Communities can become more proac-
tive in promoting healthy lifestyles (eg, greater access to
parks, trails, and other recreational opportunities). Commu-
nities also could expand programs to communicate healthy
eating patterns; some examples of successful programs of
this type are available (see Writing Group IV report).
Policies to Facilitate/Enable Recommendations
Although little research exists on the effectiveness of broad-
based policies in the prevention of obesity, it seems clear that
such programs should be developed and extensively evalu-
ated. Policies to be considered should include physical and
social environmental changes, financial incentives and tax
policies, factors related to delivery of health care, and school
and work site policies.
Several creative approaches to broad policy recommenda-
tions must be evaluated:
● Host factors, vectors, and environments must be addressed
(currently, environmental approaches are the least well
promulgated and evaluated).
● Healthcare professionals, the government, and the public
must treat the obesity epidemic seriously (too often obesity
is regarded as a cosmetic issue rather than as a health
issue).
● Serious investments are needed in interventions, programs,
monitoring, and evaluation of the obesity epidemic.
● Because knowledge alone is not enough to influence
behavior, messages and programs to counteract the obesity
epidemic must be strong and unambiguous, with a focus on
mass behavioral change.
● Large numbers of people must be encouraged to expend
higher levels of energy to blunt the obesity epidemic. In
many countries, physical activity has been largely engi-
neered out of life, with many people leading sedentary
lives. Environmental changes are central to a broad ap-
proach to address this epidemic.
It is important for medical and public health groups to
engage industry in efforts to develop and evaluate policies to
prevent obesity. Mass media, food companies, and sporting
goods companies are obvious industry partners. In addition to
promoting behaviors to maintain energy balance, industry,
especially the mass media, can help by promoting realistic
expectations about body image. Messages and images should
emphasize that diversity in body sizes and shapes is normal.
The focus should be health, not body size. Policies promoting
healthy dietary patterns must take into account consumer
factors such as taste, variety, convenience, and enjoyment.
Diets that are lower in fat and energy can be more costly than
high-fat, high-energy diets; therefore, people in lower socio-
economic groups are often at a dietary disadvantage. All
consumers want to minimize cost and maximize taste and
convenience. Advertising for healthy foods should focus on
these factors. Sporting goods companies and those providing
physical activity and fitness products and services should
help to develop policies that promote moderate-intensity
physical activity by all persons rather than the current
emphasis on competitive athletics.
Overall, primary prevention and successful treatment of
obesity will require the extensive involvement of many
sectors of society. Many of the suggestions above are un-
proved, and benefits need to be documented. Research studies
need to be longitudinal and lengthy; the cost will be expen-
sive. In the interim and without data, however, a concerted
and sustained effort is needed to focus on broad environmen-
tal changes and community support for healthy behaviors in
schools, work sites, churches, and other venues; the commit-
ment of families to healthy behaviors is critical. The need is
great and the time to address the problem of prevention and
treatment of obesity is now, even before the intervention is
evidence based.
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